Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
1999-12-17
pubmed:abstractText
Prospective studies have shown that C-reactive protein (CRP) can be used to predict risk of future cardiovascular events. High-sensitivity methods for CRP (hs-CRP) measurement are needed for this purpose.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0009-9147
pubmed:author
pubmed:issnType
Print
pubmed:volume
45
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2136-41
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:10585345-Aged, pubmed-meshheading:10585345-Aged, 80 and over, pubmed-meshheading:10585345-Antioxidants, pubmed-meshheading:10585345-Aspirin, pubmed-meshheading:10585345-C-Reactive Protein, pubmed-meshheading:10585345-Case-Control Studies, pubmed-meshheading:10585345-Double-Blind Method, pubmed-meshheading:10585345-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:10585345-Humans, pubmed-meshheading:10585345-Immunoassay, pubmed-meshheading:10585345-Latex, pubmed-meshheading:10585345-Male, pubmed-meshheading:10585345-Middle Aged, pubmed-meshheading:10585345-Myocardial Infarction, pubmed-meshheading:10585345-Peripheral Vascular Diseases, pubmed-meshheading:10585345-Platelet Aggregation Inhibitors, pubmed-meshheading:10585345-Prospective Studies, pubmed-meshheading:10585345-Risk Factors, pubmed-meshheading:10585345-Sensitivity and Specificity, pubmed-meshheading:10585345-Stroke, pubmed-meshheading:10585345-beta Carotene
pubmed:year
1999
pubmed:articleTitle
Clinical efficacy of an automated high-sensitivity C-reactive protein assay.
pubmed:affiliation
Department of Laboratory Medicine, Children's Hospital, Harvard Medical School, Boston, MA 02115, USA. rifai@a1.tch.harvard.edu
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Research Support, U.S. Gov't, P.H.S., Randomized Controlled Trial, Research Support, Non-U.S. Gov't